Prevalence of gastroparesis in patients with small duct chronic pancreatitis

Pancreas

Volumn 26, Issue 3, 2003, Pages 235-238

  Chowdhury, Riaz S ^a   Forsmark, Chris E ^a   Davis, Richard H ^a   Toskes, Phillip P ^a   Verne, G Nicholas ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gastroparesis; Minimalchange chronic pancreatitis; Small duct chronic pancreatitis

Indexed keywords

SECRETIN;

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; DISEASE SEVERITY; ENZYME THERAPY; FEEDBACK SYSTEM; FEMALE; GASTROINTESTINAL MOTILITY; HALF LIFE TIME; HUMAN; MALE; NEGATIVE FEEDBACK; PANCREAS DUCT; PANCREAS SECRETION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH EMPTYING; STOMACH PARESIS;

ADULT; CHRONIC DISEASE; FEMALE; GASTROPARESIS; HUMANS; MALE; MIDDLE AGED; PANCREATIC DUCTS; PANCREATITIS; PREVALENCE;

EID: 0037380379     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200304000-00005     Document Type: Article

References (24)

1. AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology 1998;115:763.
2. Toskes PP. Update on diagnosis and management of chronic pancreatitis. Curr Gastroenterol Rep. 1999;1:145-53.
3. Slaff J, Jacobson D, Tillman CR, et al. Protease specific suppression of pancreatic exocrine secretion. Gastroenterology 1984;87:44.
4. Isaksson G, Ihse I. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 1983;28:97.
5. Davis RH, Eaker EY, Toskes PP. Gastrointestinal dysmotility complicates management of patients with chronic pancreatitis. Gastroenterology 1996;115:A694.
6. MB Newman, PP Toskes, GN Verne. Occurrence of idiopathic gastroparesis in patients with small duct chronic pancreatitis and refractory abdominal pain. Gastroenterology 1999;116:A1174.
7. Li Y, Hao Y, Owyang C. Diazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin. J Clin Invest 2000;105:351.
8. Nakamura T, Takebe K, Ishii M. Study of gastric emptying in patients with pancreatic diabetes (chronic pancreatitis) using acetaminophen and isotope. Acta Gastroenterol Belg 1996;59:173-7.
9. Malfertheiner P, Pieramico ODK, Nelson H. Does pancreatic disease influence gastrointestinal motility? J Gastrointest Motil 1990;2:151.
10. Malfertheiner P, Pieramico O, Buchler M. Gastrointestinal motility in chronic pancreatitis. In: Beger HG, Buchler M, Ditschuneit H, et al., eds. Chronic pancreatitis. Berlin: Springer, 1990:232-4.
11. Layer P, MR Van der Ohe, JJ Holst, et al. Altered postprandial motility in chronic pancreatitis: role of malabsorption. Gastroenterology 1997;112:1624-34.
12. MK Vecht J, Eddes EH. Antroduodenal motility in chronic pancreatitis: are abnormalities related to exocrine insufficiency? Am J Physiol 2000;278:G458.
13. Somogyi L, Cintron M, Toskes PP. Synthetic porcine secretin is highly accurate in pancreatic function testing in individuals with chronic pancreatitis. Pancreas 2000;21:262-5.
14. Forsmark CE. The diagnosis of chronic pancreatitis. Gastrointest Endosc 2000; 52:293-8.
15. Hayakawa T, Kondo T, Shibata T, et al. Relationship between pancreatic exocrine function and histologic changes in chronic pancreatitis. Am J Gastroenterol 1992;87:1170-4.
16. Niederau C, Grendall J. Diagnosis of chronic pancreatitis. Gastroenterology 1985;88:1973-95.
17. Slaff J, Wolfe M, Toskes P. Elevated fasting cholecystokinin levels in pancreatic exocrine impairment: evidence to support feedback regulation. J Lab Clin Med 1985;105:282-5.
18. Gomez Cerezo J, Codoceo R, Fernandez Calle P. Basal and postprandial cholecystokinin values in chronic pancreatitis with and without abdominal pain. Digestion 1991;48:134-40.
19. Funakoshi A, Nakano I, Shinozaki H. High plasma cholecystokinin levels in patients with chronic pancreatitis having abdominal pain. Am J Gastroenterol 1986;81:1174-8.
20. Liddle RA, Morita ET, Conrad CK. Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest 1986;77:992-6.
21. Shoji E, Okamura T, Onodera S. Gastric emptying in OLETF rats not expressing CCK-A receptor gene. Dig Dis Sci 1997;42:915-9.
22. Moran TH, Kornbluh R, Moore K. Cholecystokinin inhibits gastric emptying and contracts the pyloric sphincter in rats by interacting with low affinity CCK receptor sites. Regul Pept 1994;52:165-72.
23. Fried M, Erlacher U, Schwizer W. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans: studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology 1991;101: 503-11.
24. Chowdhury RS, Forsmark CR, Bhutani MS, et al. The evaluation of unexplained pain of presumed pancreatic origin. Gastroenterology 2001;120:A760.